Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …

What Do We Need to Know About Musculoskeletal Manifestations... : JBJS Reviews What Do
We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review …

Objectives. To investigate the prevalence of neuropathic pain symptoms and to analyze the
correlation between neuropathic symptoms with pain‐related, psychological, and cognitive …

Although largely confined to the airways, SARS-CoV-2 infection has been associated with
sensory abnormalities that manifest in both acute and chronic phenotypes. To gain insight …

An extensive computer search (from January 2020 to January 2023) was conducted
including literature from the PubMed, Scopus, MEDLINE, Web of Science, and EMBASE …

We compared the prevalence of musculoskeletal post-COVID pain between previously
hospitalized COVID-19 survivors infected with the historical, Alpha or Delta SARS-CoV-2 …

Background Pain after a SARS‐CoV‐2 acute infection (post‐COVID pain) is becoming a
new healthcare emergency but remains underestimated and most likely undertreated due to …

Fibromyalgia (FM) is a complex disease with an uncertain aetiology and intricate
pathophysiology. Although its genesis is not fully explained, potential environmental factors …

Background New‐onset chronic pain has been acknowledged as part of the post‐COVID‐19
condition. However, available fine‐grained data about its clinical phenotype, trajectories and …

Rheumatology, such as other subspecialties, has both a unique perspective to offer as well
as an evolving role to play in the global COVID-19 pandemic. Our field has already …